Mcdaniel Terry & CO Abbott Laboratories Transaction History

Mcdaniel Terry & CO

$1.12 Billion
Q1 2024

A detailed history of Mcdaniel Terry & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Mcdaniel Terry & CO holds 18,338 shares of ABT stock, worth $1.91 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

18,338

Previous 19,648 6.67%

Holding current value

$1.91 Million

Previous $2.16 Million 3.65%

% of portfolio

0.19%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $143,471 - $158,457	-1,310 Reduced 6.67%	18,338 $2.08 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $82,072 - $100,464	-910 Reduced 4.43%	19,648 $2.16 Million
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $301,874 - $362,199	3,160 Added 18.16%	20,558 $1.99 Million
Q2 2023 Jul 21, 2023	SELL	$100.78 - $112.29 $22,877 - $25,489	-227 Reduced 1.29%	17,398 $1.9 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $1.71 Million - $2.01 Million	17,625 New	17,625 $1.79 Million

Q3 2021 Dec 06, 2021	SELL	$116.66 - $129.06 $1.71 Million - $1.89 Million	-14,682 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $740 - $871	7 Added 0.05%	14,682 $1.7 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $761 - $897	7 Added 0.05%	14,675 $1.76 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $525 - $572	5 Added 0.03%	14,668 $1.61 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $3,024 - $3,672	-33 Reduced 0.22%	14,663 $1.6 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $29,249 - $37,436	-382 Reduced 2.53%	14,696 $1.34 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $8,292 - $12,125	132 Added 0.88%	15,078 $1.19 Million
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $549 - $611	7 Added 0.05%	14,946 $1.3 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $41,492 - $44,991	507 Added 3.51%	14,939 $1.25 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $49,777 - $58,055	-683 Reduced 4.52%	14,432 $1.21 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $53,042 - $64,128	801 Added 5.6%	15,115 $0
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $9,309 - $10,546	-142 Reduced 0.98%	14,314 $1.04 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $25,053 - $30,224	-412 Reduced 2.77%	14,456 $1.06 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $33,275 - $36,726	578 Added 4.04%	14,868 $907,000
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $450 - $508	8 Added 0.06%	14,290 $856,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $483 - $517	9 Added 0.06%	14,282 $815,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $480 - $536	10 Added 0.07%	14,273 $762,000
Q2 2017 Aug 10, 2017	BUY	N/A	14,263	14,263 $693,000

Others Institutions Holding ABT

# of Institutions

3,133

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.69M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $183B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.

Account

Mcdaniel Terry & CO Abbott Laboratories Transaction History